Role of α2-adrenoceptors in electrical field stimulation-induced contraction of pig nasal mucosa and pharmacologic characterization of a novel α2C-adrenoceptor agonist

American Journal of Rhinology and Allergy

Volumn 27, Issue 2, 2013, Pages 84-90

  Corboz, Michel R ^a   Rivelli, Maria A ^a   Shah, Himanshu ^b   Boyce, Christopher W ^b   McCormick, Kevin D ^b   Chapman, Richard W ^a   Hunter, John C ^a  

^a Departments of Pharmacology   (United States)

^b MERCK RESEARCH LABORATORIES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA 2 ADRENERGIC RECEPTOR; ALPHA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CLONIDINE; CORTICOSTERONE; GUANOSINE 5' O (3 THIOTRIPHOSPHATE); JP 1302; N [3,4 DIHYDRO 4 (1H IMIDAZOL 4 YLMETHYL) 2H 1,4 BENZOXAZIN 6 YL] N METHYL N' METHYL UREA; PRAZOSIN; SULFUR 35; UNCLASSIFIED DRUG; YOHIMBINE;

ADRENERGIC SYSTEM; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOASSAY; CONTROLLED STUDY; ELECTROSTIMULATION; EXPERIMENTAL PIG; FEMALE; IN VITRO STUDY; MALE; MUSCLE CONTRACTILITY; NONHUMAN; NOSE MUCOSA; SENSORY NERVE; SYMPATHETIC INNERVATION;

ACRIDINES; ADRENERGIC AGONISTS; ADRENERGIC ANTAGONISTS; ANIMALS; CLONIDINE; ELECTRIC STIMULATION; EXCITATION CONTRACTION COUPLING; NASAL MUCOSA; ORGAN CULTURE TECHNIQUES; PIPERAZINES; RECEPTORS, ADRENERGIC, ALPHA-2; SAPHENOUS VEIN; SWINE; SYMPATHETIC NERVOUS SYSTEM; VASOCONSTRICTION; YOHIMBINE;

EID: 84876019707     PISSN: 19458924     EISSN: 19458932     Source Type: Journal    
DOI: 10.2500/ajra.2013.27.3842     Document Type: Article

References (39)

1. Cauna N. Blood and nerve supply of the nasal lining. In The Nose: Upper Airway Physiology and the Atmospheric Environment, Chap. 4. (Ed.) Proctor DF, and Anderson IB (Eds). Amsterdam: Elsevier, 45-69, 1982.
2. Widdicombe JG. Nasal pathophysiology. Respir Med 84:3-10, 1990.
3. Al Suleimani YM, and Walker MJA. Allergic rhinitis and its pharmacology. Pharmacol Ther 114:233-260, 2007.
4. Stull DE, Meltzer EO, Krouse JH, et al. The congestion quantifier five-item test for nasal congestion: Refinement of the congestion quantifier seven-item test. Am J Rhinol Allergy 24:34-38, 2010.
5. Sarin S, Undem B, Sanico A, and Togias A. The role of the nervous system in rhinitis. J Allergy Clin Immunol 118:999-1016, 2006.
6. Wandalsen GF, Mendes AI, and Solé D. Objective improvement in nasal congestion and nasal hyperreactivity with use of nasal steroids in persistent allergic rhinitis. Am J Rhinol Allergy 24:32-36, 2010.
7. Varty LM, and Hey JA. Histamine H3 receptor activation inhibits neurogenic sympathetic vasoconstriction in porcine nasal mucosa. Eur J Pharmacol 452:339-345, 2002.
8. Thompson DC, Diamond L, and Altiere RJ. Presynaptic alpha adrenoceptor modulation of neurally mediated cholinergic excitatory and nonadrenergic noncholinergic inhibitory responses in guinea pig trachea. J Pharmacol Exp Ther 254:306-311, 1990.
9. Grundstrom N, Andersson RGG, and Wikberg JES. Prejunctional alpha2 adrenoceptors inhibit contraction of tracheal smooth muscle by inhibiting cholinergic neurotransmission. Life Sci 29:2981-2996, 1981.
10. Doidge JM, and Satchell DG. Adrenergic and non-Adrenergic inhibitory nerves in mammalian airways. J Auton Nerv Syst 5:83-99, 1982.
11. Ramnarine SI, Hirayama Y, Barnes PJ, and Rogers DF. Sensoryefferent neural control of mucus secretion: Characterization using tachykinin receptor antagonists in ferret trachea in vitro. Br J Pharmacol 113:1183-1190, 1994.
12. Varty LM, Gustafson E, Laverty M, and Hey JA. Activation of histamine H3 receptors in human nasal mucosa inhibits sympathetic vasoconstriction. Eur J Pharmacol 484:83-89, 2004.
13. Lacroix JS, and Lundberg JM. Sympathetic vascular control of the pig nasal mucosa: Adrenoceptor mechanisms in blood flow and volume control. Br J Pharmacol 97:1075-1084, 1989.
14. Kawarai M, and Koss MC. Sympathetic control of nasal blood flow in the rat mediated by 1-Adrenoceptors. Eur J Pharmacol 413:255-262, 2001.
15. Corboz MR, Varty LM, Rizzo CA, et al. Pharmacological characterization of 2-Adrenoceptor-mediated responses in pig nasal mucosa. Auton Autac Pharmacol 23:208-219, 2003.
16. Corboz MR, Rivelli MA, McCormick KD, et al. Pharmacological characterization of the novel 2C-Adrenoceptor agonist N-[3,4-Dihydro-4-(1H- imidazol-4-ylmethyl)-2H-1,4-Benzoxazin-6-yl]-N-ethyl-N-methylurea (Compound A). J Pharmacol Exp Ther 337:256-266, 2011.
17. Mingo GG, Corboz MR, Salisbury BG, et al. Alpha-2c-Adrenergic receptors contribute to basal nasal patency in the anesthetized cat. Pharmacology 85:259-263, 2010.
18. Stafford-Smith M, Bartz R, Wilson K, et al. Alpha-Adrenergic mRNA subtype expression in the human nasal turbinate. Can J Anesth 54:549-555, 2007.
19. Baraniuk JN. Neural regulation of mucosal function. Pulm Pharmacol Ther 21:442-448, 2008.
20. Sallinen J, Hoglund I, Engstrom M, et al. Pharmacological characterization and CNS effects of a novel highly selective 2C-Adrenoceptor antagonist JP-1302. Brit J Pharmacol 150:391-402, 2007.
21. Aslanian RG, Mangiaracina P, De Lera Ruiz M, et al. Inventors; Schering Corp., assignee. Preparation of imidazolylmethylbenzoxazines and related compounds as 2c adrenoceptor agonists. World patent WO 024949. March 1, 2007.
22. Wadell C, Björk E, and Camber O. Nasal drug delivery-Evaluation of an in vitro model using porcine nasal mucosa. Eur J Pharm Sci 7:197-206, 1999.
23. Jackson RT. A new in vitro method of drug assay of nasal blood vessels. Arch Otorhinolaryngol 225:33-38, 1979.
24. Rizzo CA, Ruck LM, Corboz MR, et al. Postjunctional 2c-Adrenoceptor contractility in human saphenous vein. Eur J Pharmacol 413:263-269, 2001.
25. Corboz MR, Mutter JC, Rivelli MA, et al. 2-Adrenoceptor agonists as nasal decongestants. Pulm Pharmacol Ther 20:149-156, 2007.
26. Corboz MR, Rivelli MA, Mingo GG, et al. Mechanism of decongestant activity of 2-Adrenoceptor agonists. Pulm Pharmacol Ther 21: 449-454, 2008.
27. Corboz MR, Rivelli MA, Varty LM, et al. Pharmacological characterization of postjunctional -Adrenoceptor in human nasal mucosa. Am J Rhinol 19:495-502, 2005.
28. Robie NW. Evaluation of presynaptic alpha-receptor function in the canine renal vascular bed. Am J Heart 239:H422-H426, 1980.
29. Knaus AE, Muthig V, Schickinger S, et al. 2-Adrenoceptor subtypes-Unexpected functions for receptors and ligands derived from gene-Targeted mouse models. Neurochem Int 51:277-281, 2007.
30. Baraniuk JN. Sensory, parasympathetic, and sympathetic neural influences in the nasal mucosa. J Allergy Clin Immunol 90:1045-1050, 1992.
31. Wang M, and Lung MA. Acetylcholine induces contractile and relaxant effects in canine nasal venous systems. Eur Respir J 28:839-846, 2006.
32. Lung MA. M1 and M3 muscarinic receptors mediate relaxation and contraction in canine nasal veins. Am J Rhinol Allergy 25:60-65, 2011.
33. Rogers DF. Pharmacological regulation of the neuronal control of airway mucus secretion. Curr Opin Pharmacol 2:249-255, 2002.
34. Baraniuk JN, and Kaliner M. Neuropeptides and nasal secretion. Am J Physiol 261:L223-L235, 1991.
35. Baraniuk JN, Lundgren JD, Okayama M, et al. Substance P and neurokinin A in human nasal mucosa. Am J Respir Cell Mol Biol 4:228-236, 1991.
36. Shirasaki H, Kanaizumi E, Watanabe K, et al. Expression of neurokinin A receptor mRNA in human nasal mucosa. Acta Otolaryngol S:85-89, 2004.
37. Kaise T, Akamatsu Y, Ikemura T, et al. Involvement of neuropeptides in the allergic nasal obstruction in guinea pigs. Jpn J Pharmacol 86:196-202, 2001.
38. Pettipher R, Hansel TT, and Armer R. Antagonism of the prostaglandin D2 receptors DP1 and CRTH2 as an approach to treat allergic diseases. Nat Rev Drug Discov 6:313-325, 2007.
39. Corboz MR, Rivelli MA, Skeans S, et al. Vasodilatory and secretagogue roles of the prostaglandin D2 (PGD2) receptor in nasal mucosa and airways of different species. Am J Respir Crit Care Med 179: A5699, 2009.